This program provides brand name medications at no or low cost.
Pharmaceutical Company GlaxoSmithKline
Program Name GlaxoSmithKline Bridges to Access
Program Address PO Box 29038
Phoenix, AZ 85038-9038
Phone Number

866-728-4368

Fax Number
Medications on Program Ziagen Tablets  (abacavir)
Application Forms GlaxoSmithKline Bridges to Access
On-line Application
No on-line application available at this time
Web Site Click to go to program's web site
Eligibility Guidelines and Notes

The patient must have no prescription coverage for the requested medication and have an income at or below 250% of the Federal Poverty Level. Medical diagnosis necessary for this program is not specified. The patient must also be a US resident. Bridges to Access has new enrollment instructions. It's no longer required to enroll via an advocate unless the patient requires immediate access to their medicine. Applicants can enroll by mailing a completed application, a current prescription and income documentation. An advocate, however, must call to enroll Bridges to Access applicants who need immediate access to medicine (please see web page http://www.bridgestoaccess.com/ for further details about the two methods of enrollment). If the patient chooses not to enroll in Part D and is not eligible for the Low Income Subsidy Program, then s/he may eligible for this program. The application can be filled out and printed on the website, but each application need an individual number (which the website does automatically.)

Application Process

Anyone requesting assistance can call the above number to request an application be mailed or faxed out or download it from the website. The application can be faxed, mailed out or downloaded from website. The completed application must be mailed back.  The patient is notified in writing of acceptance or denial.  

Application Requirements

The doctor must fill out a section, sign the application and attach a prescription. The patient must fill out a section, sign the application, and attach proof of income and any denial letters from insurance companies.

Program Details

Up to a 90-day supply is sent to the patient's home. The patient must contact the company to arrange for refills. Once a year the application process must be repeated.

Last Updated September 09, 2009